Estradiol induced inhibition of 11β-hydroxysteroid dehydrogenase 1: An explanation for the postmenopausal hormone replacement therapy effects

Medical Hypotheses

Volumn 64, Issue 5, 2005, Pages 989-991

  Cohen, Paul G ^a  

^a MERCER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; ANTIINFLAMMATORY AGENT; ESTRADIOL; HYDROCORTISONE; INSULIN; ISOENZYME;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; BREAST CARCINOMA; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE COURSE; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; ENZYME INHIBITION; FEMALE; FRAGILITY FRACTURE; GENDER; HORMONE SUBSTITUTION; HORMONE SYNTHESIS; HUMAN; INCIDENCE; INFLAMMATION; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; LUNG EMBOLISM; MENOPAUSAL SYNDROME; OSTEOPOROSIS; PNEUMONIA; PRIORITY JOURNAL; RISK FACTOR; SIDE EFFECT; STROKE; TREATMENT OUTCOME; VASCULAR DISEASE;

EID: 15244362373     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2004.11.004     Document Type: Article

References (13)

1. J.E. Rossouw, G.L. Anderson, R.L. Prentice, A.Z. LaCroix, C. Kooperberg, and M.L. Stefanick Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Iniative Investigators JAMA 288 2002 321 333
2. R.G. Barr, C.C. Wentowski, and F. Grodstein Prospective study of postmenopausal hormone use and newly diagnosed asthma and chronic obstructive lung disease Arch Intern Med 164 2004 379 386
3. A.M. Kanaya, D. Herrington, W. Vittinghoff, F. Lin, D. Grady, and V. Bittner Glycemic effects of postmenopausal hormonal therapy: the heart and estrogen/progestin replacement study Ann Intern Med 138 2003 1 9
4. D.J. Torpy, and G.P. Chrousos The three-way interactions between the hypothalamic-pituitary-adrenal and gonadal axes and immune system Baillieres Clin Rheumatol 10 1996 181 198
5. A. Blum, and E. Maser Enzymology and molecular biology of glucocorticoid metabolism in humans Prog Nucleic Acid Res 75 2003 173 216
6. A.P. Ligeiro de Oliveira, R.M. Oliveira-Filho, Z.L. da Silva, P. Borelli, and W. Tavares de Lima Regulation of allergic lung inflammation in rats: interaction between estradiol and cortico-sterone Neuroimmunomodulation 11 2004 20 27
7. A.K. Agarwal Cortisol metabolism and visceral obesity: role of 11beta-hydroxysteroid dehydrogenase 1 enzyme and reduced co-factor NADPH Endo Res 29 2003 411 418
8. R.W. Alexander The Jeremiah Metzger Lecture. Pathogenesis of atherosclerosis: redox as a unifying mechaism Trans Am Clin Climatol Assoc 114 2003 273 304
9. M.S. Cooper, E.A. Walker, R. Bland, W.D. Fraser, M. Hewison, and P.M. Stewart Expression and functional consequences of 11beta-hydroxysteroid dehydrogenase activity in human bone Bone 27 2000 375 381
10. E.H. Rabbitt, N.J. Gittoes, P.M. Stewart, and M. Hewison 11beta-hydroxysteroid dehydrogenases, cell proliferation and malignancy J Steroid Biochem Mol Biol 85 2003 415 421
11. P.G. Cohen Aromatase, adiposity, aging and disease. The hypogonadal-metabolic-atherogenic-disease and aging connection Med Hypotheses 56 2001 702 708
12. H. Morita, Y. Isomura, T. Mune, H. Daido, R. Takami, and N. Yamakita Plasma cortisol and cortisone concentrations in normal subjects and patients with adrenocortical disorders Metabolism 53 2004 89 94
13. G.P. Chrousos Is 11beta-HSD type 1 a good therapeutic target for blockade of glucocorticoid actions ? PNAS 101 2004 6329 6330